Daniel P. Cahill

Also affiliated with Massachusetts General Hospital, Mass General Brigham

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4

Acta Neuropathologica(2023)10.1007/s00401-023-02609-6

Top 16%

1.3DataRank

Top 16%66 citations

Priscilla K. Brastianos, Hiroaki Wakimoto, Amir Zolal, Mariella G. Filbin, Daniel P. Cahill +3 more

Papers

Driven by 62 papers — median percentile 0. Top paper: “BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas”.

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

New England Journal of Medicine(2023)10.1056/nejmoa2213329

N/A

4.5DataRank · unranked

138 citations

Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Shervin Tabrizi +23 more

Evolution of delayed resistance to immunotherapy in a melanoma responder

Nature Medicine(2021)10.1038/s41591-021-01331-8

N/A

3.6DataRank · unranked

137 citations

Jia‐Ren Lin, Emily Robitschek, Gyulnara G. Kasumova, Alex Heyde, Alvin Shi +35 more

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0870

N/A

1.6DataRank · unranked

53 citations

Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matt Lastrapes, Matthew R. Strickland +40 more

Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results

Nature Medicine(2023)10.1038/s41591-023-02392-7

N/A

1.6DataRank · unranked

66 citations

Albert E. Kim, Anita Giobbie‐Hurder, Eudocia Q. Lee, Nancy U. Lin, Beth Overmoyer +28 more

A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4

Acta Neuropathologica(2023)10.1007/s00401-023-02609-6

Top 16%

1.3DataRank

Top 16%66 citations

Priscilla K. Brastianos, Hiroaki Wakimoto, Amir Zolal, Mariella G. Filbin, Daniel P. Cahill +3 more

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Cell(2019)10.1016/j.cell.2019.06.024

N/A

1.2DataRank · unranked

2765 citations

Julie Laffy, Mariella G. Filbin, Toshiro Hara, Marni E. Shore, Gilbert J. Rahme +59 more

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

Science(2017)10.1126/science.aai8478

N/A

1.0DataRank · unranked

1050 citations

Itay Tirosh, Christine Hebert, Keren Yizhak, Cyril Neftel, Mariella G. Filbin +29 more

Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells

Cell(2014)10.1016/j.cell.2014.02.030

N/A

1.0DataRank · unranked

949 citations

Matthew A. Reyna, Daniel A. Gilchrist, Anoop P. Patel, Hiroaki Wakimoto, Samuel D. Rabkin +21 more

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2502

N/A

0.964DataRank · unranked

24 citations

Erin Twohy, Elizabeth R. Gerstner, Timothy J. Kaufmann, A. John Iafrate, Suriya Jeyapalan +16 more

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

Cell(2021)10.1016/j.cell.2021.01.022

N/A

0.897DataRank · unranked

394 citations

Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M. Perez, Sascha Marx +38 more

Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2000

N/A

0.718DataRank · unranked

119 citations

Hiroaki Nagashima, Jianfang Ning, Mara V.A. Koerner, Hiroaki Wakimoto, Daniel P. Cahill +1 more

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases

Nature Communications(2021)10.1038/s41467-021-25860-5

N/A

0.637DataRank · unranked

69 citations

Christopher Alvarez‐Breckenridge, Samuel C. Markson, Albert E. Kim, Robert H. Klein, Naema Nayyar +24 more

Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma

Cancer Cell(2024)10.1016/j.ccell.2024.03.008

N/A

0.614DataRank · unranked

59 citations

Simon Gritsch, Masashi Nomura, Alexander Jucht, Jérôme Fortin, Ramya Raviram +25 more

De Novo Pyrimidine Synthesis is a Targetable Vulnerability in IDH Mutant Glioma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.30.470443

N/A

0.611DataRank · unranked

11 citations

Milan R. Savani, Michael M. Levitt, Adam C. Wang, Jennifer E. Endress, Cylaina Bird +38 more

ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma

Neuro-Oncology(2021)10.1093/neuonc/noab292

N/A

0.590DataRank · unranked

50 citations

Kimberly Wang, Ceylan Damon, Yi Fu, Tengjiao Ma, Lisa E. Kratz +9 more

A rapid genotyping panel for detection of primary central nervous system lymphoma

Blood(2021)10.1182/blood.2020010137

N/A

0.564DataRank · unranked

42 citations

Evan Burns, N. Zeke Georgantas, Julia Thierauf, Naema Nayyar, Amanda Gordon +24 more

Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2000

N/A

0.457DataRank · unranked

20 citations

Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Michael W. Ruff +15 more

An integrated RF-receive/B0-shim array coil boosts performance of whole-brain MR spectroscopic imaging at 7 T

Scientific Reports(2020)10.1038/s41598-020-71623-5

N/A

0.434DataRank · unranked

17 citations

Jason Stockmann, Bernhard Strasser, Nicolas Arango, Bijaya Thapa, Zhe Wang +9 more

Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group

Neuro-Oncology(2024)10.1093/neuonc/noae231

N/A

0.434DataRank · unranked

17 citations

Jacob S. Young, Gilbert C Youssef, Antonio Dono, Levin Häni, Tommaso Sciortino +25 more

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

Pigment Cell & Melanoma Research(2022)10.1111/pcmr.13059

N/A

0.425DataRank · unranked

16 citations

Maya Dimitrova, Kevin Kleffman, Christopher Alvarez‐Breckenridge, Michael B. Atkins, Adrienne Boire +22 more

A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology

Neuro-Oncology(2024)10.1093/neuonc/noae276

N/A

0.425DataRank · unranked

16 citations

Michael B. Keough, Jeffrey Zuccato, Rahul Kumar, Sebastian C Schulz, Arthur E. Warrington +14 more

Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1056

N/A

0.373DataRank · unranked

11 citations

Leland G. Richardson, Jing Sun, Rishab Ramapriyan, Maria Martinez-Lage, Julie J. Miller +5 more

142 Genetic and Nongenetic Determinants of Cellular Architecture in IDH1-Mutant Oligodendrogliomas and Astrocytomas Using Single-Cell Transcriptome Analysis

Neurosurgery(2016)10.1227/01.neu.0000489712.44702.0d

N/A

0.330DataRank · unranked

3 citations

Itay Tirosh, Christine Hebert, Robert L. Martuza, Brian V. Nahed, William T. Curry +7 more

Improving D‐2‐hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF‐receive/B0‐shim array coils at 3 T

NMR in Biomedicine(2021)10.1002/nbm.4621

N/A

0.330DataRank · unranked

8 citations

Nicolas Arango, Jason Stockmann, Borjan Gagoski, Bijaya Thapa, Xianqi Li +11 more

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

Neuro-Oncology(2023)10.1093/neuonc/noad236

N/A

0.323DataRank · unranked

6 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade

Neurosurgical FOCUS(2024)10.3171/2023.11.focus23694

N/A

0.269DataRank · unranked

5 citations

Leland G. Richardson, Jing Sun, Rishab Ramapriyan, Maria Martinez-Lage, Julie J. Miller +4 more

Deep-ER: Deep Learning ECCENTRIC Reconstruction for fast high-resolution neurometabolic imaging

NeuroImage(2025)10.1016/j.neuroimage.2025.121045

N/A

0.208DataRank · unranked

3 citations

Georg Langs, Wolfgang Bogner, Stanislav Motyka, Bernhard Strasser, Polina Golland +9 more

A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma

Cancers(2025)10.3390/cancers17132178

N/A

0.208DataRank · unranked

3 citations

Eric P. Grewal, Rishab Ramapriyan, Leland G. Richardson, Gust Vandecandelaere, Adrian Kalaw +9 more

Inductively coupled, transmit-receive coils for proton MRI and X-nucleus MRI/MRS in small animals

Journal of Magnetic Resonance Open(2023)10.1016/j.jmro.2023.100123

N/A

0.104DataRank · unranked

1 citations

Jitendra Sharma, David Guarin, Julie Miller, Hiroaki Wakimoto, Daniel P. Cahill +2 more

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac185

N/A

0DataRank · unranked

76 citations

Ambike Aarti Srivastava, Rishab Ramapriyan, Stefanie R. Bailey, Amanda A. Bouffard, Daniel P. Cahill +17 more

De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma

Cancer Cell(2022)10.1016/j.ccell.2022.07.011

N/A

0DataRank · unranked

131 citations

Milan R. Savani, Michael M. Levitt, Adam C. Wang, Jennifer E. Endress, Cylaina Bird +46 more

Deep learning super-resolution magnetic resonance spectroscopic imaging of brain metabolism and mutant isocitrate dehydrogenase glioma

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac071

N/A

0DataRank · unranked

12 citations

Bernhard Strasser, Ulf Neuberger, Philipp Kickingereder, Martin Bendszus, Wolfgang Wick +5 more

Zinc Finger MYND-Type Containing 8 (ZMYND8) is epigenetically regulated in mutant Isocitrate Dehydrogenase 1 (IDH1) glioma to promote radioresistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.10.495694

N/A

0DataRank · unranked

3 citations

Kaushik Banerjee, Anzar Mujeeb, Brandon Zhu, Santiago Haase, María L. Varela +20 more

Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.25.456956

N/A

0DataRank · unranked

0 citations

Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matthew Lastrapes, Matthew R. Strickland +39 more

Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma

Neuropathology and Applied Neurobiology(2021)10.1111/nan.12773

N/A

0DataRank · unranked

13 citations

Kathrine Grell, Tareq A. Juratli, Felix Sahm, Sabine Spiegl‐Kreinecker, Matthieu Peyre +18 more

Microscale Physiological Events on the Human Cortical Surface

Cerebral Cortex(2021)10.1093/cercor/bhab040

N/A

0DataRank · unranked

49 citations

Jimmy C. Yang, Daniel R. Cleary, Daniel J. Soper, Mila Halgren, Alexandra R. O’Donnell +38 more

Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-1896

N/A

0DataRank · unranked

11 citations

Kaushik Banerjee, Anzar Mujeeb, Brandon Zhu, Santiago Haase, María L. Varela +21 more

Evidence-based recommendations on categories for extent of resection in diffuse glioma

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.002

N/A

0DataRank · unranked

209 citations

Michael A. Vogelbaum, Martin J. van den Bent, Daniel P. Cahill, Lorenzo Bello, Yoshitaka Narita +4 more

Advanced imaging to assess longitudinal vascular changes in brain metastases treated with immune checkpoint inhibition.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2529

N/A

0DataRank · unranked

0 citations

Ken Chang, Andrew Beers, Kyrre E. Emblem, Jayashree Kalpathy–Cramer, Eudocia Q. Lee +15 more

Glioblastoma-infiltrating CD8 + T cells are predominantly a clonally expanded GZMK + effector population

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.25.554678

N/A

0DataRank · unranked

2 citations

Bryce L. Mashimo, Maximilian O. Schaettler, Ngima D. Sherpa, Lydia A. Leavitt, Alexandra J. Livingstone +16 more

Data from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

(2023)10.1158/0008-5472.c.6495272.v1

N/A

0DataRank · unranked

0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Supplementary Information from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

Figshare(2023)10.1158/0008-5472.22366754.v1

Top 100%

0DataRank

Top 100%0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Supplementary Information from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

(2023)10.1158/0008-5472.22366754

Top 100%

0DataRank

Top 100%0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Data from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

(2023)10.1158/0008-5472.c.6495272

N/A

0DataRank · unranked

0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Data from MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

(2023)10.1158/1078-0432.c.6517996

N/A

0DataRank · unranked

0 citations

Jiangyong Miao, Daniel P. Cahill, A. John Iafrate, Ken Aldape, Catherine L. Nutt +2 more

Data from Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype

(2023)10.1158/1078-0432.c.6519516

N/A

0DataRank · unranked

0 citations

Jun Wei, Wei Qiao, Mustafa Aziz Hatiboğlu, Ling‐Yuan Kong, Adam Wu +8 more

Data from MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

(2023)10.1158/1078-0432.c.6517996.v1

N/A

0DataRank · unranked

0 citations

Jiangyong Miao, Daniel P. Cahill, A. John Iafrate, Ken Aldape, Catherine L. Nutt +2 more

Data from Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype

(2023)10.1158/1078-0432.c.6519516.v1

N/A

0DataRank · unranked

0 citations

Jun Wei, Wei Qiao, Mustafa Aziz Hatiboğlu, Ling‐Yuan Kong, Adam Wu +8 more

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.25.554868

N/A

0DataRank · unranked

0 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity

Science(2024)10.1126/science.adl6173

N/A

0DataRank · unranked

93 citations

Hiroshi Kondo, Ashwin V. Kammula, Lei Shi, Yi Xiao, Sofiene Dhiab +33 more

MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma

Neuro-Oncology(2020)10.1093/neuonc/noaa212

N/A

0DataRank · unranked

6 citations

Daniel P. Cahill, Julie J. Miller

CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0562

N/A

0DataRank · unranked

23 citations

Lisa Melamed, Ethan A. Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa +5 more

Sirtuin activation targets IDH-mutant tumors

Neuro-Oncology(2020)10.1093/neuonc/noaa180

N/A

0DataRank · unranked

31 citations

Alexandria L. Fink, Jack A Banagis, Hiroaki Nagashima, Megha Subramanian, Christine K. Lee +6 more

Extent of Resection of Glioblastoma

Neurosurgery Clinics of North America(2020)10.1016/j.nec.2020.09.006

N/A

0DataRank · unranked

33 citations

Daniel P. Cahill

Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma

Neuro-Oncology(2024)10.1093/neuonc/noae073

N/A

0DataRank · unranked

19 citations

William J. Smith, Joseph D. Bradley, Eric Esposito, Mihir Gupta, Evan Burns +19 more

Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma

Cancer Research(2020)10.1158/0008-5472.can-20-1094

N/A

0DataRank · unranked

52 citations

Ameya R. Kirtane, Juri Kiyokawa, Hiroaki Nagashima, Aaron Lopes, Zain A. Tirmizi +5 more

Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0226

N/A

0DataRank · unranked

101 citations

Christine K. Lee, Kensuke Tateishi, Fumi Higuchi, Megha Subramanian, Seamus Rafferty +5 more

Deep-ER: Deep Learning ECCENTRIC Reconstruction for fast high-resolution neurometabolic imaging

arXiv (Cornell University)(2024)10.48550/arxiv.2409.18303

N/A

0DataRank · unranked

0 citations

Georg Langs, Wolfgang Bogner, Stanislav Motyka, Bernhard Strasser, Polina Golland +9 more

A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group

The Lancet Oncology(2025)10.1016/s1470-2045(25)00534-0

N/A

0DataRank · unranked

17 citations

Jacob S. Young, Maarten M.J. Wijnenga, Tommaso Sciortino, Nico Teske, Alba Corell +44 more

“Real world” use of a highly reliable imaging sign: “T2-FLAIR mismatch” for identification of IDH mutant astrocytomas

Neuro-Oncology(2020)10.1093/neuonc/noaa041

N/A

0DataRank · unranked

137 citations

Derek R. Johnson, Sohil H. Patel, Maurício Castillo, Marion Smits, Martin J. van den Bent +3 more

GENT-16. REDEFINING THE CELLULAR ARCHITECTURE OF ADULT AND PEDIATRIC GLIOBLASTOMAS THROUGH LARGE-SCALE SINGLE-CELL ANALYSES

Neuro-Oncology(2016)10.1093/neuonc/now212.322

N/A

0DataRank · unranked

0 citations

Itay Tirosh, Cyril Neftel, Volker Hovestadt, Christine Hebert, McKenzie Shaw +17 more

Unsupervised learning of metabolic fingerprints from 3D magnetic resonance spectroscopic imaging enables glioma subtype classification

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf220

N/A

0DataRank · unranked

0 citations

Paul J Weiser, Jörg Dietrich, Daniel P. Cahill, Ovidiu C. Andronesi, Gülnur Ungan

Daniel P. Cahill

Indexed papers

Top data-sharing exemplar

Papers